Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Patient Preference × delta 24-sterol reductase × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Patient Satisfaction 2 Urologic Neoplasms 1 Thyroid Cancer, Papillary 1 Radiation Injuries 1 Patient Preference 1 Patient Acceptance of Health Care 1 Neoplasms 1 Breast Neoplasms 1

Interventions

delta 24-sterol reductase 1 daratumumab 1 Validation Studies as Topic 1 Tape Recording 1 Pilot Projects 1 Focus Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05236218 2023-03-08

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

King's College London

Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡